Regulation of B cell function by the immunosuppressive agent leflunomide

Transplantation
K F SiemaskoA Finnegan

Abstract

Leflunomide is an immunosuppressive drug capable of inhibiting cellular and humoral mediated responses in vivo. The mechanism responsible for suppression of B cell antibody responses in vivo has not been identified. In this study we demonstrate that leflunomide functions to inhibit murine B cell antibody production by directly acting on the B cell. Experiments performed in vivo showed that both T cell-dependent as well as T cell-independent antigen responses were suppressed by leflunomide. Initial in vitro experiments demonstrated that leflunomide inhibited B cell antibody production by decreasing B cell proliferation. The suppression of B cell proliferation induced by a variety of stimuli that use different signal cascade components suggested that leflunomide was acting on a common component required for B cell proliferation. Kinetic studies with LPS activated B cells revealed that leflunomide retained its inhibitory activity when added as late as 24 hr after stimulation in an 88-hr assay. By analyzing the cell cycle of LPS-stimulated B cells we observed that leflunomide targets two different stages in cell cycle transition: (1) from G1 to S phase and (2) from S phase to G2/M phase. Analysis of one of the cyclin-dependent kina...Continue Reading

References

Jul 1, 1985·Cell·M K BijsterboschG G Klaus
Sep 1, 1988·Biochemical Pharmacology·G SchwartsmannH M Pinedo
Jan 1, 1988·Scandinavian Journal of Rheumatology. Supplement·R R BartlettR X Raiss
Dec 1, 1986·Agents and Actions·S Popovic, R R Bartlett
Aug 1, 1982·The Journal of Cell Biology·T PozzanT J Rink
Jan 1, 1993·Springer Seminars in Immunopathology·R R BartlettR Schleyerbach

❮ Previous
Next ❯

Citations

Apr 24, 2013·Current Treatment Options in Neurology·Tiffany J Braley, Benjamin M Segal
Nov 8, 2013·CNS Drugs·Karly P Garnock-Jones
Apr 24, 2013·Drugs·Rehiana AliPaolo Antonio Muraro
Mar 27, 2001·Transplantation Proceedings·J WooR Buelow
Feb 1, 1997·Transplantation Proceedings·A CheungR Morris
Jun 24, 1998·Transplantation Proceedings·D A GerberA W Thomson
Nov 18, 1998·International Journal of Immunopharmacology·D W HoskinT D Lee
Dec 14, 1999·The British Journal of Surgery·S A White, M L Nicholson
Mar 9, 2002·Transplantation·James W WilliamsStephen Jensik
Mar 25, 2008·Transplantation·Tobias DeuseSonja Schrepfer
Jan 16, 2007·Annals of the Rheumatic Diseases·J M van WoerkomJ W J Bijlsma
Oct 29, 2000·Annals of the Rheumatic Diseases·F C Breedveld, J M Dayer
May 19, 2005·Arthritis Research & Therapy·Bernhard M KirschMarcus D Säemann
Jun 1, 2011·Drug Design, Development and Therapy·Richard NicholasPaolo A Muraro
Mar 29, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Nicolae LecaConnie L Davis
Sep 30, 2010·Immunotherapy·Sven Teschner, Volker Burst
Dec 29, 1998·Transplantation Proceedings·Z Qi, H Ekberg
Apr 18, 2014·Drugs·Amit Bar-OrHeinz Wiendl
Jul 24, 1998·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·T UhligP D Sly
Jun 22, 2005·Treatments in Endocrinology·Daniel M RidgwayRachel M Kimber
Dec 14, 2012·Expert Review of Clinical Pharmacology·Athina PapadopoulouTill Sprenger
Jan 1, 2006·Expert Review of Clinical Immunology·Gary Kunkel, Grant W Cannon
May 21, 2013·Expert Opinion on Drug Metabolism & Toxicology·Michael D WieseCatherine O'Doherty
Jan 1, 1997·Expert Opinion on Investigational Drugs·H T Silva, R E Morris

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.